EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency
Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring
proceedings without self-administration
16-Jul-2026 / 23:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by [1]EQS News – a service of
[2]EQS Group.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Korneuburg, Austria, 16^th July 2026 – Marinomed Biotech AG (VSE:MARI)
announces the plan to apply for the initiation of a court restructuring
proceeding without self-administration. The application is being filed
because the court-approved restructuring plan dated November 14, 2024,
cannot be fulfilled due to the breakdown of negotiations by Unither and
the failure of Unither Pharmaceuticals to make earn-out payments from the
sale of the Carragelose business unit, thereby placing the company at risk
of insolvency. The aim of the renewed restructuring proceedings without
self-administration is to secure the company’s financial stability by
concluding a new restructuring plan. In addition to further restructuring
measures, the legal options available against Unither arising from the
sale of the Carragelose business and the assets of the Marinosolv platform
are to be utilized.
+++ End of ad-hoc announcement +++
End of Inside Information
══════════════════════════════════════════════════════════════════════════
16-Jul-2026 CET/CEST News transmitted by [3]EQS Group
View original content: [4]EQS News
══════════════════════════════════════════════════════════════════════════
Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Phone: +43 2262 90300
E-mail: office@marinomed.com
Internet: www.marinomed.com
ISIN: ATMARINOMED6
WKN: A2N9MM
Listed: Regulated Unofficial Market in Dusseldorf, Frankfurt, Munich,
Stuttgart, Tradegate BSX; Vienna Stock Exchange (Official
Market)
LEI Code: 529900GN3B1EN80XF405
EQS News ID: 2367244
End of Announcement EQS News Service
2367244 16-Jul-2026 CET/CEST
https://nwr.eqs-cockpit.com/fncls2.ssx?application_id=2367244&application_name=news&site_id=apa_ots_austria~~
References
~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
2. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=f5d50dc7e8798b6eb177f7955e598e60&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
3. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=f5d50dc7e8798b6eb177f7955e598e60&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
4. https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&url=b687579a860aa32349feba5e0c206854&application_id=2367244&site_id=apa_ots_austria~~~18b544d0-9c71-4160-bd95-cc8b9aff9fbf&application_name=news
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender